Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
archive
medical
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
government
medicine
research
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tc
abbvie
acorda therapeutics
akcea therapeutics
alder biopharmaceuticals
alivecor
alnylam pharmaceuticals
amgen
ampyra
andrew fire
apokyn
apomorphine
artificial intelligence
biotech
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cannabis
cdc
chronic migraine
coronavirus
What
drug
10
×
fda
10
×
gets
10
×
food
administration
treatment
approval
called
announced
approved
authorization
breakthrough
compound
designation
disease
disorder
granted
help
kids
medicine
new
nod
patients
young
ability
acorda
administ
advisers
afternoon
ages
aid
alivecor
alnylam
alnylam’s
amgen
announcement
anticipated
asd
authorized
autism
Language
unset
Current search:
drug
×
fda
×
gets
×
@slashgear.com
2 years ago
Pfizer COVID-19 vaccine gets FDA panel recommendation for young kids
@slashgear.com
3 years ago
Autism diagnosis software gets FDA authorization
@slashgear.com
4 years ago
Another company gets FDA designation to treat depression with psilocybin
@slashgear.com
4 years ago
Another popular heartburn drug gets FDA cancer warning
@slashgear.com
4 years ago
Superbug tuberculosis treatment gets FDA approval as cases skyrocket
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@techcrunch.com
5 years ago
Alivecor gets a green light from FDA to screen for dangerously high potassium levels in the blood
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines